AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
AnGes EPS Diluted (Quarterly): -0.0921 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0921 |
| September 30, 2023 | 0.0011 |
| June 30, 2023 | -0.0747 |
| March 31, 2023 | -0.1205 |
| December 31, 2022 | -0.1964 |
| September 30, 2022 | -0.131 |
| June 30, 2022 | -0.2263 |
| March 31, 2022 | -0.1653 |
| December 31, 2021 | -0.099 |
| September 30, 2021 | -0.2685 |
| June 30, 2021 | -0.2547 |
| March 31, 2021 | -0.2344 |
| December 31, 2020 | -0.079 |
| September 30, 2020 | -0.0989 |
| June 30, 2020 | -0.0745 |
| March 31, 2020 | -0.0786 |
| December 31, 2019 | -0.0843 |
| September 30, 2019 | -0.0695 |
| June 30, 2019 | -0.0672 |
| March 31, 2019 | -0.1082 |
| December 31, 2018 | -0.074 |
| September 30, 2018 | -0.1088 |
| June 30, 2018 | -0.0671 |
| March 31, 2018 | -0.0615 |
| December 31, 2017 | -0.045 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1214 |
| June 30, 2017 | -0.0934 |
| March 31, 2017 | -0.1837 |
| December 31, 2016 | -0.1236 |
| September 30, 2016 | -0.1468 |
| June 30, 2016 | -0.2396 |
| March 31, 2016 | -0.1888 |
| December 31, 2015 | -0.1656 |
| September 30, 2015 | -0.1401 |
| June 30, 2015 | -0.1717 |
| March 31, 2015 | -0.1386 |
| December 31, 2014 | -0.0455 |
| September 30, 2014 | -0.3058 |
| June 30, 2014 | -0.1364 |
| March 31, 2014 | -0.1365 |
| December 31, 2013 | -0.1407 |
| September 30, 2013 | -0.088 |
| June 30, 2013 | 0.0813 |
| March 31, 2013 | -0.1222 |
| December 31, 2012 | -0.1856 |
| September 30, 2012 | -0.1473 |
| June 30, 2012 | -0.1893 |
| March 31, 2012 | -0.1979 |
| December 31, 2011 | -0.2769 |
| September 30, 2011 | -0.1741 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2685
Minimum
Sep 2021
0.0011
Maximum
Sep 2023
-0.127
Average
-0.0989
Median
Sep 2020
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.2265 |
| Nxera Pharma Co Ltd | -0.0144 |
| PeptiDream Inc | -0.0263 |
| Stemcell Holdings Inc | 0.04 |
| Healios KK | -0.1655 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.88M |
| Revenue (Quarterly) | 0.3408M |
| Total Expenses (Quarterly) | 19.03M |
| Enterprise Value | 37.97M |
| Gross Profit Margin (Quarterly) | 14.39% |
| Profit Margin (Quarterly) | -5.24K% |
| Earnings Yield | -85.33% |
| Normalized Earnings Yield | -67.62 |